Suscríbase a nuestro boletín para estar al día
Haga clic aquí
  • BLS

Safety guide: Asbestos

BLS Safety Guide: Asbestos


A guide written by Dr. Antonio Moffa, Dr. Claudia Beccaria and Lucrezia Giorgi of the Unit of Integrated Therapies in Otolaryngology at the University Polyclinic Campus Bio-Medical Foundation in Rome.

 

In the five-year period 2016-2020, an average of about 1,500 workers per year were recognised as having an asbestos-related disease. In the same years, around 50% of workers who contracted asbestos-related diseases suffered a permanent impairment of no more than 25%, while 37% of technopaths died as a result of the occupational disease. Specifically in 2016, the proportion of workers with an impairment of no more than 25 per cent remained almost unchanged, but those with a fatal outcome rose to 43 per cent.

The use of asbestos was banned in Italy in 1992 with Law No. 257, which set the terms and procedures for the cessation of all activities involving the processing and extraction of this mineral. After this date, the only permitted work activities involving exposure to asbestos are its clearance, removal and disposal.

The IARC (International Agency for Research on Cancer) has classified asbestos as a human carcinogen (Group 1).

The danger of asbestos derives from the degree of fibre freedom, i.e. the ability of asbestos-containing materials to release potentially inhalable fibres into the air. Since asbestos is a friable and fibrous material, it is easy for very small particles to be released into the air as a result of any type of stress (processing and handling, vibrations, infiltration of humidity), which, once inhaled, are capable of being deposited in the pulmonary alveoli, bronchi and pleura, causing irreversible tissue damage and the onset of pulmonary diseases. Moreover, as there is no risk threshold below which the concentration of asbestos fibres in the air is not dangerous, it follows that the inhalation of even a single fibre can cause fatal pathologies; clearly, prolonged exposure over time or to high quantities will exponentially increase the likelihood of contracting such pathologies.

The European Commission has recently approved an exposure limit value (or TLV) 10 times lower than the previous one (0.1 fibres/cm3), i.e. 0.01 fibres/cm3, for an 8-hour exposure reference. The harmful effects that occur following the inhalation of asbestos particles are derived from pathogenic mechanisms of an irritative, degenerative and carcinogenic nature and can lead to the onset of various diseases.

The pathologies resulting from breathing in asbestos fibres are all characterised by a long interval between the start of exposure and the appearance of the first symptoms of the disease: this interval, termed 'latency time', can generally last up to decades.

From these pathologies related to exposure to asbestos derives the importance of worker protection, which must be on several fronts: the worker must be equipped with personal respiratory protective equipment with an operational protection factor that ensures that the filtered air inside the PPE is no more than 1/10 of the limit value. The use of PPE must also be interspersed with rest periods appropriate to the physical effort required by the work, and the employer must carry out periodic measurements of the concentration of fibres in the air, reporting the results in the DVR (Risk Assessment Document).

 

 

Recommended products:

 

 

 

Stay informed
Stay safe.

 

Artículos relacionados

mayo 20, 2022 Biological agents transmissibility

Agenti biologici e trasmissibilità Alcune vie di trasmissione infettano con maggiore probabilità di altre. In generale, se ne possono individuare tre macro-categorie: la trasmissione diretta, la tramissione indiretta e la tramissione da vettori.   TRASMISSIONE DIRETTA   Trasmissione per ingestione Può trattarsi di ingestione accidentale tramite aerosol o droplet ad esempio. Per droplet si intende […]

Link
octubre 13, 2021 A+A 2021 | Coming soon

Fiera A+A 2021 26-29 ottobre 2021 | Düsseldorf, Germania   La trentasettesima edizione della fiera A+A di Düsseldorf è ormai vicina. Come professionisti del settore da oltre 50 anni, non potevamo perdere l'occasione di essere presenti all’evento di riferimento a livello mondiale per il settore della protezione individuale e della sicurezza e salute sul lavoro. Dopo quasi due anni di incontri virtuali, […]

Link
noviembre 6, 2018 ExpoProtection Exhibition 2018 - Paris

Il team BLS ti invita a EXPOPROTECTION 2018 La mostra di prevenzione e gestione del rischio. Un evento di riferimento per il mercato della prevenzione, che riunisce circa 750 espositori internazionali e riceve più di 20.000 visitatori. Per 3 giorni, ExpoProtection si concentrerà sulle competenze e sull'innovazione per consentire ai suoi visitatori di comprendere gli […]

Link
Suscríbete al boletín
Reciba actualizaciones sobre nuestros eventos, noticias, catálogo y próximas iniciativas.
Suscribir

Contáctenos

Escríbanos para todas sus necesidades, le responderemos dentro de las 48 horas.
Información requerida

BLS S.R.L.
Società a Socio Unico
via dei Giovi, 41 - 20032 Cormano (MI) - Italia
t/f +39 02 39310212 / 66200473
info@blsgroup.it
Privacy Policy - Cookie Policy

Oficina registrada
via dei Giovi, 41 – 20032 Cormano (MI) - Italia
Capitale Sociale | Share Capital: Euro 600.000,00 i.v.
C.C.I.A.A. - R.E.A.: MI 1186898
Partita IVA | VAT N°: IT12296780153
C.F. e Iscrizione al Registro delle Imprese di Milano: 07822320151

BLS IBERIA / Av. Pau Casals, 8 08182 Sant Feliu de Codines Barcelona - Spain
BLS NORTHWEST / Reeweg, 132 3343 AP H.I. Ambacht Rotterdam - The Netherlands
BLS DO BRASIL / Rua Alvarenga Peixoto, 307 05095-010 Sao Paulo - SP - Brazil
BLS GERMANY / Dünner Straße 249 D-41066 Mönchengladbach - Germany
BLS FRANCE / 18 Porte du Grand Lyon 01700 Neyron - France

crossmenuchevron-downcross-circle